| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |